Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer

BACKGROUND: Increased health care costs have made it incumbent on health-care facilities and physicians to demonstrate both clinical and cost efficacy when recommending treatments. Though studies have examined the cost-effectiveness of adjuvant goserelin with radiotherapy for locally advanced prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Tsui Fen, Wang, Jung Der, Uen, Wu Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296644/
https://www.ncbi.nlm.nih.gov/pubmed/22264299
http://dx.doi.org/10.1186/1471-2407-12-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296644/
https://www.ncbi.nlm.nih.gov/pubmed/22264299
http://dx.doi.org/10.1186/1471-2407-12-33

Ejemplares similares